(Reuters) -U.S. drugmaker Pfizer and venture firm Flagship Pioneering on Tuesday said they would invest $100 million together to develop…
Acumen’s Alzheimer’s drug passes initial safety test
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Alzheimer’s disease drug developed by Acumen Pharmaceuticals targeting a novel form of…
US FDA approves Sarepta’s gene therapy for rare muscular dystrophy in some kids
By Leroy Leo and Aditya Samal (Reuters) – The U.S. health regulator has granted accelerated approval to Sarepta Therapeutics’ first-of-its-kind…
Bezos’ Blue Origin wins NASA contract to build astronaut lunar lander
By Joey Roulette WASHINGTON (Reuters) -A team led by Jeff Bezos’ Blue Origin won a coveted $3.4 billion NASA contract…
Luminar, Mercedes-Benz expand deal for self-driving tech
(Reuters) – Self-driving sensor maker Luminar Technologies Inc announced an expanded partnership with Mercedes-Benz Group on Wednesday to enable fully…
Airlines cancel over 1,300 U.S. flights as winter storm grips states
(Reuters) -Airlines canceled more than 1,300 flights in the United States on Wednesday as a strong winter storm makes its…
Amazon grants 1.5 million euros to Dutch seaweed farm project
AMSTERDAM (Reuters) – Amazon.com has granted 1.5 million euros ($1.6 million) to a Dutch project testing the viability of commercially…
Elon Musk says end-2023 ‘good timing’ to find new Twitter head
By Yousef Saba DUBAI (Reuters) – Twitter Chief Executive Elon Musk said on Wednesday that towards the end of 2023…
Many companies and finance firms yet to set deforestation policy – report
By Simon Jessop LONDON (Reuters) – Almost half of the companies most reliant on the commodities responsible for deforestation, and…
U.S. ‘disappointed’ in Mexico’s new GMO corn decree -ag secretary
By Leah Douglas WASHINGTON (Reuters) – The United States said on Tuesday it was “disappointed” in the Mexican government’s announcement…